fashion -WSS

fashion

author：entertainment 2025-09-29 20:52:27 - browse：9357

It’s no secret that biotech industry funding has fallen from its Covid highs. But with just a few months left in the year, it’s on track to hit lows that predate the pandemic.

New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly. So far this year, there have been 1,384 VC deals struck in the field, the lowest figure since 2013. For comparison, there were roughly 2,122 financing deals made last year.

If dealmaking remains consistent for the rest of the year, it would put this year on par with the number of deals made in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Air quality improving but still lags in Black, Hispanic communities

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

The problem with charging patients to message their doctors

RSV shot was 90% effective at preventing hospitalizations in kids

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Amylyx ALS drug failure raises questions and concerns

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Wikipedia

fashion

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Report cites 'urgent' need to recruit more diverse clinical trial participants

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Boddities: What happens to the brain when we get scared?

Medical leaders decry Supreme Court decision on affirmative action

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Artificial intelligence use in health care faces greater scrutiny in 2024

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Congress must protect the remaining independent doctors

explore

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Report cites 'urgent' need to recruit more diverse clinical trial participants

NEJM study link tiny plastics in blood vessels to heart problems

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Tome Biosciences co

Wikipedia

leisure time

explore

focus